Given the MND treatment landscape has "darkened" in recent months, with failed drugs exiting the healthcare market, one would "reasonably expect" the USFDA to be keen to "be seen as active" in the space and award the ODD.....we are however dealing with the FDA.......so we humbly await word, to come down from near Almighty High! aaaaAAAAAAAMMMMmmeeeeennnnnn.....
Given the MND treatment landscape has "darkened" in recent...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.5¢ | 21.0¢ | $325.8K | 1.512M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 236217 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 78289 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.005 ( 2.23 %) |
||||
| Open | High | Low | Volume | ||
| 21.5¢ | 22.5¢ | 21.0¢ | 629786 | ||
| Last updated 15.58pm 03/06/2024 ? | |||||
| PAA (ASX) Chart |